Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction

Africa has the highest incidence of mortality caused by infectious diseases, and remarkably does not have the capacity to manufacture vaccines that are essential to reduce mortality, improving life expectancy, and promoting economic growth. GAVI has significantly helped introduction of new vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Makenga, Geofrey, Bonoli, Stefano, Montomoli, Emanuele, Carrier, Trent, Auerbach, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435488/
https://www.ncbi.nlm.nih.gov/pubmed/30949465
http://dx.doi.org/10.3389/fpubh.2019.00056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435488/
https://www.ncbi.nlm.nih.gov/pubmed/30949465
http://dx.doi.org/10.3389/fpubh.2019.00056

Ejemplares similares